<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:georss="http://www.georss.org/georss" xmlns:geo="http://www.w3.org/2003/01/geo/wgs84_pos#" xmlns:media="http://search.yahoo.com/mrss/"
		>
<channel>
	<title>Comments on: Twitter awareness/engagement ratio: a pillory or a pedestal for pharma?</title>
	<atom:link href="http://stwem.com/2010/01/08/pharma-awareness-engagement-ratio/feed/" rel="self" type="application/rss+xml" />
	<link>http://stwem.com/2010/01/08/pharma-awareness-engagement-ratio/</link>
	<description></description>
	<lastBuildDate>Tue, 31 Jan 2012 17:31:21 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.com/</generator>
	<item>
		<title>By: Headline Commentary Jan 23-Jan 31 &#124; Health Content Advisors</title>
		<link>http://stwem.com/2010/01/08/pharma-awareness-engagement-ratio/#comment-887</link>
		<dc:creator><![CDATA[Headline Commentary Jan 23-Jan 31 &#124; Health Content Advisors]]></dc:creator>
		<pubDate>Wed, 03 Feb 2010 19:16:14 +0000</pubDate>
		<guid isPermaLink="false">http://stwem.com/?p=1232#comment-887</guid>
		<description><![CDATA[[...] » Twitter awareness/engagement ratio: a pillory or a pedestal for pharma &#8230; [...]]]></description>
		<content:encoded><![CDATA[<p>[...] » Twitter awareness/engagement ratio: a pillory or a pedestal for pharma &#8230; [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Who Follows Big Pharma On Twitter? - Better Health</title>
		<link>http://stwem.com/2010/01/08/pharma-awareness-engagement-ratio/#comment-882</link>
		<dc:creator><![CDATA[Who Follows Big Pharma On Twitter? - Better Health]]></dc:creator>
		<pubDate>Tue, 02 Feb 2010 14:00:34 +0000</pubDate>
		<guid isPermaLink="false">http://stwem.com/?p=1232#comment-882</guid>
		<description><![CDATA[[...] each provided great insight into Pharma and Twitter. You can read their posts here and here, [...]]]></description>
		<content:encoded><![CDATA[<p>[...] each provided great insight into Pharma and Twitter. You can read their posts here and here, [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: andrewspong</title>
		<link>http://stwem.com/2010/01/08/pharma-awareness-engagement-ratio/#comment-874</link>
		<dc:creator><![CDATA[andrewspong]]></dc:creator>
		<pubDate>Fri, 22 Jan 2010 10:52:44 +0000</pubDate>
		<guid isPermaLink="false">http://stwem.com/?p=1232#comment-874</guid>
		<description><![CDATA[Hi Silja

Thanks for stopping by to leave a comment. We should do some work together. ;)

The &lt;a href=&quot;http://www.whydotpharma.com/2010/01/20/pharma-twittersphere-who-is-following-you-part-i/&quot; rel=&quot;nofollow&quot;&gt;analysis&lt;/a&gt; you are doing of the pharma Twittersphere is great, and I am very much looking forward to part 2.

I&#039;m predicting that the second part of your analysis will reveal that pharma accounts are currently mostly being followed by pharma employees, the agencies and ancillaries that work with them, pundits and analysts. Perhaps the occasional healthcare professional, but scant numbers, and only those who take an adjacent interest in Health 2.0 which may have little to do with their day job.

What I do not expect to see are scores of people-patients or patient community accounts hanging on pharma&#039;s every word.

From this speculative perspective, pharma&#039;s Twitter activities to date have been an unmitigated failure. If all they want to do is engage the communities they already work with and know, they may as well pick up the phone.

So, we&#039;re back to basics, namely:

Why is pharma using Twitter?
What does it want to achieve?
Which communities is pharma trying to reach?
How is pharma measuring its success, and what is it measuring?
How is it going to adapt its activity in order to improve on the above?
What&#039;s next?

]]></description>
		<content:encoded><![CDATA[<p>Hi Silja</p>
<p>Thanks for stopping by to leave a comment. We should do some work together. <img src='http://s1.wp.com/wp-includes/images/smilies/icon_wink.gif' alt=';)' class='wp-smiley' /> </p>
<p>The <a href="http://www.whydotpharma.com/2010/01/20/pharma-twittersphere-who-is-following-you-part-i/" rel="nofollow">analysis</a> you are doing of the pharma Twittersphere is great, and I am very much looking forward to part 2.</p>
<p>I&#8217;m predicting that the second part of your analysis will reveal that pharma accounts are currently mostly being followed by pharma employees, the agencies and ancillaries that work with them, pundits and analysts. Perhaps the occasional healthcare professional, but scant numbers, and only those who take an adjacent interest in Health 2.0 which may have little to do with their day job.</p>
<p>What I do not expect to see are scores of people-patients or patient community accounts hanging on pharma&#8217;s every word.</p>
<p>From this speculative perspective, pharma&#8217;s Twitter activities to date have been an unmitigated failure. If all they want to do is engage the communities they already work with and know, they may as well pick up the phone.</p>
<p>So, we&#8217;re back to basics, namely:</p>
<p>Why is pharma using Twitter?<br />
What does it want to achieve?<br />
Which communities is pharma trying to reach?<br />
How is pharma measuring its success, and what is it measuring?<br />
How is it going to adapt its activity in order to improve on the above?<br />
What&#8217;s next?</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Silja</title>
		<link>http://stwem.com/2010/01/08/pharma-awareness-engagement-ratio/#comment-873</link>
		<dc:creator><![CDATA[Silja]]></dc:creator>
		<pubDate>Fri, 22 Jan 2010 10:39:58 +0000</pubDate>
		<guid isPermaLink="false">http://stwem.com/?p=1232#comment-873</guid>
		<description><![CDATA[Fascinating post, Andrew. It is true that twitter engagement has many dimensions to it. The cold, hard facts of numbers of following, followers, updates and lists only give indicators. They are all part of the puzzle, but do not tell the story. 

What I have witnessed though, over and over again, that there are little surprises, if you do follow the path of engagement, it shows.

In the next couple of days, I will release analysis on who is following pharma at the moment, by size of their following, segment and how many other pharma accounts they follow... we will see if this hypothesis holds, if pharmaco&#039;s that engage have a different quality of audience than those that don&#039;t.

It seems to me that twitter has been an experiment more than a concrete strategic initiative to engage with x or y stakeholder for most pharmacos so far.

The quality though of the audience you manage to engage with will be the true indicator of pharma&#039;s success on twitter. We all know this, but now we have to make it visible, prove it, make the case. Thanks for this attempt. It is definately one further step in that direction. :)]]></description>
		<content:encoded><![CDATA[<p>Fascinating post, Andrew. It is true that twitter engagement has many dimensions to it. The cold, hard facts of numbers of following, followers, updates and lists only give indicators. They are all part of the puzzle, but do not tell the story. </p>
<p>What I have witnessed though, over and over again, that there are little surprises, if you do follow the path of engagement, it shows.</p>
<p>In the next couple of days, I will release analysis on who is following pharma at the moment, by size of their following, segment and how many other pharma accounts they follow&#8230; we will see if this hypothesis holds, if pharmaco&#8217;s that engage have a different quality of audience than those that don&#8217;t.</p>
<p>It seems to me that twitter has been an experiment more than a concrete strategic initiative to engage with x or y stakeholder for most pharmacos so far.</p>
<p>The quality though of the audience you manage to engage with will be the true indicator of pharma&#8217;s success on twitter. We all know this, but now we have to make it visible, prove it, make the case. Thanks for this attempt. It is definately one further step in that direction. <img src='http://s0.wp.com/wp-includes/images/smilies/icon_smile.gif' alt=':)' class='wp-smiley' /> </p>
]]></content:encoded>
	</item>
	<item>
		<title>By: PhilFeed &#8250; Fresh From My Twitter today</title>
		<link>http://stwem.com/2010/01/08/pharma-awareness-engagement-ratio/#comment-841</link>
		<dc:creator><![CDATA[PhilFeed &#8250; Fresh From My Twitter today]]></dc:creator>
		<pubDate>Wed, 20 Jan 2010 01:43:46 +0000</pubDate>
		<guid isPermaLink="false">http://stwem.com/?p=1232#comment-841</guid>
		<description><![CDATA[[...] Awareness/Engagement (Twitter) Ratio, by @andrewspong &#8211; http://bit.ly/7D7lL6 &#8211; #SocPharm    This was written by Phil. Posted on Wednesday, January 20, 2010, at 1:33 am. [...]]]></description>
		<content:encoded><![CDATA[<p>[...] Awareness/Engagement (Twitter) Ratio, by @andrewspong &#8211; <a href="http://bit.ly/7D7lL6" rel="nofollow">http://bit.ly/7D7lL6</a> &#8211; #SocPharm    This was written by Phil. Posted on Wednesday, January 20, 2010, at 1:33 am. [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Matt</title>
		<link>http://stwem.com/2010/01/08/pharma-awareness-engagement-ratio/#comment-822</link>
		<dc:creator><![CDATA[Matt]]></dc:creator>
		<pubDate>Fri, 08 Jan 2010 21:30:08 +0000</pubDate>
		<guid isPermaLink="false">http://stwem.com/?p=1232#comment-822</guid>
		<description><![CDATA[Great article! Our company made the list (PhysioGenix) and we appreciate the recognition. We do need to engage more with our followers, as right now our Twitter is mostly a bull horn, and not a telephone.]]></description>
		<content:encoded><![CDATA[<p>Great article! Our company made the list (PhysioGenix) and we appreciate the recognition. We do need to engage more with our followers, as right now our Twitter is mostly a bull horn, and not a telephone.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: andrewspong</title>
		<link>http://stwem.com/2010/01/08/pharma-awareness-engagement-ratio/#comment-819</link>
		<dc:creator><![CDATA[andrewspong]]></dc:creator>
		<pubDate>Fri, 08 Jan 2010 07:53:54 +0000</pubDate>
		<guid isPermaLink="false">http://stwem.com/?p=1232#comment-819</guid>
		<description><![CDATA[Thanks David! When I&#039;ve finished wrestling with the table so that you can actually see what it contains, it will be even better ;)]]></description>
		<content:encoded><![CDATA[<p>Thanks David! When I&#8217;ve finished wrestling with the table so that you can actually see what it contains, it will be even better <img src='http://s1.wp.com/wp-includes/images/smilies/icon_wink.gif' alt=';)' class='wp-smiley' /> </p>
]]></content:encoded>
	</item>
	<item>
		<title>By: David Bradley</title>
		<link>http://stwem.com/2010/01/08/pharma-awareness-engagement-ratio/#comment-818</link>
		<dc:creator><![CDATA[David Bradley]]></dc:creator>
		<pubDate>Fri, 08 Jan 2010 07:41:21 +0000</pubDate>
		<guid isPermaLink="false">http://stwem.com/?p=1232#comment-818</guid>
		<description><![CDATA[Thanks for the shout out Andrew. Glad to have inspired your post interesting to see such a neat list of pharmas on Twitter.

As to engaging with new followers...it gets very hard to keep up if you&#039;re getting dozens every day. I&#039;m being forced to ignore the vast majority unless I see immediately that we have mutual interests or they retweet me.]]></description>
		<content:encoded><![CDATA[<p>Thanks for the shout out Andrew. Glad to have inspired your post interesting to see such a neat list of pharmas on Twitter.</p>
<p>As to engaging with new followers&#8230;it gets very hard to keep up if you&#8217;re getting dozens every day. I&#8217;m being forced to ignore the vast majority unless I see immediately that we have mutual interests or they retweet me.</p>
]]></content:encoded>
	</item>
</channel>
</rss>

